Hingmed -About Hingmed

中文

blood pressure monitor solution Hingmed blood pressure monitor&ventilator

Home page

All Categories>

Social Responsibility

Hingmed, the global leader in Ambulatory Blood Pressure Monitor and Ventilator technology

Founded in 2014, Hingmed Medical Instrument Co., Ltd. has established as a pioneer in the medical technology field, boasting a decade of expertise in delivering innovative healthcare solutions. With a strong focus on ambulatory blood pressure monitors (ABPM), blood pressure kiosks, and respiratory ventilator products, Hingmed’s dedicated research and development team continually pushes the boundaries of medical innovation.

Our products are trusted and endorsed by prestigious organizations such as the European Society of Hypertension (ESH), the British and Irish Hypertension Society (BIHS), Dabl Educational Trust, and STRIDE BP. Hingmed’s blood pressure monitors have earned CE and FDA certifications, underscoring our commitment to quality and safety. As a global leader in the manufacture of blood pressure monitoring devices, Hingmed is dedicated to enhancing lives through cutting-edge research, unparalleled innovation, and impactful educational efforts.

Guided by our vision, "Let everyone more healthy," and driven by our mission, "To deliver premium ABPM, blood pressure kiosk, and respiratory technology," we strive for excellence in advancing healthcare and improving patient outcomes worldwide.

History of Hingmed

2014

In January, Hingmed was established, and the second-class medical device production license was obtained.

2015

In January, Hingmed launched our 24-hour ambulatory blood pressure monitors, Model No.: ABP-03 and ABP-03B.

In July, Hingmed launched the first wearable 24-hour ambulatory blood pressure monitors, Model No.:WBP-02A.

In August, the company obtained ISO13485 quality system certification. The ABP and WBP series ambulatory blood pressure monitors passed CE certification.

2016

In November, Hingmed obtained the "National High-tech Enterprise" certification.

2017

In April, WBP-02A ambulatory blood pressure monitor was successfully introduced in the French market.

2018

In March, the WBP-02A ambulatory blood pressure monitor passed the clinical validation of the European Society of Hypertension (ESH) and became a recommended product by the European Society of Hypertension and Dabl Educational Trust.

2019

In September, the ambulatory blood pressure monitor WBP-02A was successfully introduced to the Italian market and has been used in telemedicine.

2020

In August,Hingmed signed up a strategic cooperation with the School of Biomedical Engineering at Shenzhen University.

In December, Hingmed launched the Fully Automatic Blood Pressure Monitors DBP-01P,and DBP-01HP.

2021

In March, DBP-01P medical automatic electronic sphygmomanometer successfully entered the Thai market, serving more than 50 public and private hospitals in Thailand

In May, DBP-01P participated in the United Nations aid project in Africa, DBP-01P began to serve major public hospitals in Ethiopia.

In August, Hingmed obtained the invention patent for an anti-interference blood pressure algorithm from the State Intellectual Property Office.

In September, the DBP-1P series medical automatic electronic sphygmomanometer and ABP, WBP series ambulatory blood pressure monitor made a huge breakthrough in the Southeast Asian market and gained market recognition.

In November, WBP-02A ambulatory blood pressure monitor was certified by UKCA and became a recommended product by BIHS (British Society of Hypertension).

2022

In June, Hingmed became a strategic partner of JD.com, Hingmed Wireless Blood Pressure Monitors Q06B, V03, and V03D started to be sold on JD.com.

In November, Hingmed Fully Automatic BP monitor DBP-01P passed the clinical validation according to ISO 81060-2:2018 protocol.

In December, the European market was further developed, and DBP-01P series medical automatic electronic blood pressure monitors and ABP-03, WBP-02A series ambulatory blood pressure monitors, and other products were exported to the United Kingdom, Italy, Spain, France, Poland, and other countries.

In December, the company focused on technology research and development. Over the years, it has achieved 13 software copyrights, 24 patents including invention patents, and many other patents are in the process of application.

2023

Clinical Automatic Blood Pressure Monitor DBP-01P was listed as a “Recommended” device on Dabl Educational Trust .

2024

In January, a Decade of Innovation: Hingmed's 10th Anniversary.
In March, Clinical Automatic Blood Pressure Monitors, DBP-01P and DBP-01HP, have successfully obtained FDA approval through the 510(k) clearance process.
In June, Hingmed's non-invasive ventilator series has received approval from the State Food and Drug Administration.

The Hingmed Range

Shenzhen Hingmed Medical Instrument Co., Ltd.

Partners

Honor qualification

Enterprise culture